Company Filing History:
Years Active: 2022
Title: Eli Attar - Innovator in Cardiac Screening Technology
Introduction
Eli Attar is a notable inventor based in Rosh-Ha′ayin, Israel. He has made significant contributions to the field of cardiac health through his innovative approach to voice analysis. His work focuses on developing methods that can potentially revolutionize how cardiac conditions are diagnosed.
Latest Patents
Eli Attar holds a patent for a groundbreaking method titled "Verbal periodic screening for heart disease." This invention involves analyzing a voice sample from a subject to determine various cardiac conditions, such as arrhythmias. The method includes extracting at least one voice feature from the sample, detecting the impact of the cardiac condition on that feature, and ultimately determining the cardiac condition based on the observed effects. Additionally, the patent describes a system designed to assess the cardiac condition from the voice sample provided by the subject.
Career Highlights
Eli Attar is associated with Cardiokol Ltd., a company dedicated to advancing cardiac health technologies. His work at Cardiokol Ltd. emphasizes the integration of voice analysis into routine cardiac screenings, which could lead to earlier detection and better management of heart diseases.
Collaborations
Eli collaborates with talented individuals in his field, including Yirmiyahu Hauptman and Alon Goren. Their combined expertise contributes to the innovative projects at Cardiokol Ltd.
Conclusion
Eli Attar's contributions to cardiac health through his patent on voice analysis represent a significant advancement in medical technology. His work has the potential to improve early detection of heart conditions, ultimately benefiting patient care.